Treating KRAS-mutant NSCLC: latest evidence and clinical consequences.
Saved in:
| Title: | Treating KRAS-mutant NSCLC: latest evidence and clinical consequences. |
|---|---|
| Authors: | Garrido P; Head of Thoracic Tumor Unit, Medical Oncology Department, Hospital Universitario Ramón y Cajal, Facultad de Medicina. Universidad de Alcalá (IRYCIS) Carretera Colmenar Viejo KM 9100, 28034 Madrid, Spain., Olmedo ME; Medical Oncology Department, Hospital Universitario Ramón y Cajal. Facultad de Medicina. Universidad de Alcalá (IRYCIS), Madrid, Spain., Gómez A; Medical Oncology Department, Hospital Universitario Ramón y Cajal. Facultad de Medicina. Universidad de Alcalá (IRYCIS), Madrid, Spain., Paz Ares L; Centro de Investigaciones Biomédicas en Red en Cáncer (CIBER-ONC), Madrid, Spain; Medical Oncology Department, Hospital Universitario Doce de Octubre, Universidad Complutense and Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid, Spain., López-Ríos F; Centro de Investigaciones Biomédicas en Red en Cáncer (CIBER-ONC), Madrid, Spain Hospital Universitario HM Sanchinarro C/ Oña, 10. 28050 Madrid, España., Rosa-Rosa JM; Centro de Investigaciones Biomédicas en Red en Cáncer (CIBER-ONC), Madrid, Spain., Palacios J; Centro de Investigaciones Biomédicas en Red en Cáncer (CIBER-ONC), Madrid, Spain Servicio de Anatomía Patológica, Hospital Universitario Ramón y Cajal, Universidad de Alcalá (IRYCIS), Madrid, Spain. |
| Source: | Therapeutic advances in medical oncology [Ther Adv Med Oncol] 2017 Sep; Vol. 9 (9), pp. 589-597. Date of Electronic Publication: 2017 Jul 24. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Sage Country of Publication: England NLM ID: 101510808 Publication Model: Print-Electronic Cited Medium: Print ISSN: 1758-8340 (Print) Linking ISSN: 17588340 NLM ISO Abbreviation: Ther Adv Med Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 29081842 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Treating KRAS-mutant NSCLC: latest evidence and clinical consequences. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Garrido+P%22">Garrido P</searchLink>; Head of Thoracic Tumor Unit, Medical Oncology Department, Hospital Universitario Ramón y Cajal, Facultad de Medicina. Universidad de Alcalá (IRYCIS) Carretera Colmenar Viejo KM 9100, 28034 Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Olmedo+ME%22">Olmedo ME</searchLink>; Medical Oncology Department, Hospital Universitario Ramón y Cajal. Facultad de Medicina. Universidad de Alcalá (IRYCIS), Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Gómez+A%22">Gómez A</searchLink>; Medical Oncology Department, Hospital Universitario Ramón y Cajal. Facultad de Medicina. Universidad de Alcalá (IRYCIS), Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Paz+Ares+L%22">Paz Ares L</searchLink>; Centro de Investigaciones Biomédicas en Red en Cáncer (CIBER-ONC), Madrid, Spain; Medical Oncology Department, Hospital Universitario Doce de Octubre, Universidad Complutense and Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22López-Ríos+F%22">López-Ríos F</searchLink>; Centro de Investigaciones Biomédicas en Red en Cáncer (CIBER-ONC), Madrid, Spain Hospital Universitario HM Sanchinarro C/ Oña, 10. 28050 Madrid, España.<br /><searchLink fieldCode="AU" term="%22Rosa-Rosa+JM%22">Rosa-Rosa JM</searchLink>; Centro de Investigaciones Biomédicas en Red en Cáncer (CIBER-ONC), Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Palacios+J%22">Palacios J</searchLink>; Centro de Investigaciones Biomédicas en Red en Cáncer (CIBER-ONC), Madrid, Spain Servicio de Anatomía Patológica, Hospital Universitario Ramón y Cajal, Universidad de Alcalá (IRYCIS), Madrid, Spain. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101510808%22">Therapeutic advances in medical oncology</searchLink> [Ther Adv Med Oncol] 2017 Sep; Vol. 9 (9), pp. 589-597. <i>Date of Electronic Publication: </i>2017 Jul 24. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Review – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Sage%22">Sage </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101510808 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Print <i>ISSN: </i>1758-8340 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2217588340%22">17588340 </searchLink><i>NLM ISO Abbreviation: </i>Ther Adv Med Oncol <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=29081842 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1177/1758834017719829 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 589 Titles: – TitleFull: Treating KRAS-mutant NSCLC: latest evidence and clinical consequences. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Garrido P – PersonEntity: Name: NameFull: Olmedo ME – PersonEntity: Name: NameFull: Gómez A – PersonEntity: Name: NameFull: Paz Ares L – PersonEntity: Name: NameFull: López-Ríos F – PersonEntity: Name: NameFull: Rosa-Rosa JM – PersonEntity: Name: NameFull: Palacios J IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 09 Text: 2017 Sep Type: published Y: 2017 Identifiers: – Type: issn-print Value: 1758-8340 Numbering: – Type: volume Value: 9 – Type: issue Value: 9 Titles: – TitleFull: Therapeutic advances in medical oncology Type: main |
| ResultId | 1 |
